AML bone marrow was stained with CD34 and CD38 antibodies to subcategorize into LSCs (CD34+CD38-) and Blasts (CD34+CD38+) (Supplementary Figure 1B). The gene discussed is CD38; the disease is acute myeloid leukemia.